Thomas Graney

2018

In 2018, Thomas Graney earned a total compensation of $2.9M as Former SVP & Chief Financial Officer at Vertex Pharmaceuticals, a 52% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$367,538
Option Awards$606,332
Salary$550,000
Stock Awards$1,400,130
Other$13,685
Total$2,937,685

Graney received $1.4M in stock awards, accounting for 48% of the total pay in 2018.

Graney also received $367.5K in non-equity incentive plan, $606.3K in option awards, $550K in salary and $13.7K in other compensation.

Rankings

In 2018, Thomas Graney's compensation ranked 3,947th out of 14,244 executives tracked by ExecPay. In other words, Graney earned more than 72.3% of executives.

ClassificationRankingPercentile
All
3,947
out of 14,244
72nd
Division
Manufacturing
1,454
out of 5,765
75th
Major group
Chemicals And Allied Products
516
out of 2,128
76th
Industry group
Drugs
433
out of 1,817
76th
Industry
Pharmaceutical Preparations
337
out of 1,391
76th

Pay ratio

Thomas Graney's Pay$2,937,685
Median Employee's Pay$232,178
Pay Ratio

13

to 1

In 2018, the annual total compensation of Thomas Graney was $2,937,685.

The annual total compensation of the median employee at Vertex Pharmaceuticals was $232,178.

The ratio of Thomas Graney's pay to the pay of median employee was therefore 13 to one.

Source: SEC filing on April 26, 2019.

Graney's colleagues

We found six more compensation records of executives who worked with Thomas Graney at Vertex Pharmaceuticals in 2018.

2018

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2018

Jeffrey Chodakewitz

Vertex Pharmaceuticals

Chief Medical Officer

2018

Amit Sachdev

Vertex Pharmaceuticals

EVP & Chief Regulatory Officer

2018

Michael Parini

Vertex Pharmaceuticals

EVP & Chief Legal and Administrative Officer

2018

Stuart Arbuckle

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2018

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

News

You may also like